A Framework to Guide the Optimal Development and Use of Real-World Evidence for Drug Coverage and Formulary Decisions

Journal of Comparative Effectiveness Research- United Kingdom

doi 10.2217/cer-2018-0059

Full Text

Abstract

Available in

Categories

Date

December 1, 2018

Authors

Steven D Pearson

William B Dreitlein

Publisher

Future Medicine Ltd

Related search

Real-World Evidence to Guide the Approval and Use of New Treatments

NAM Perspectives

English

Report on the Current Status of the Use of Real‐world Data (RWD) and Real‐world Evidence (RWE) in Drug Development and Regulation

British Journal of Clinical Pharmacology

English

Pcp53 - A Diagnostic Framework to Evaluate Real-World Data Sources for Real-World Evidence Generation

Value in Health

Occupational Health

English

A Structured Pre‐ and Post‐Approval Comparative Study Design Framework to Generate Valid and Transparent Real‐World Evidence for Regulatory Decisions

Clinical Pharmacology and Therapeutics

English

The Microtomist's Formulary and Guide

American Journal of Public Health and the Nations Health

English

National Drug Policies to Local Formulary Decisions in Thailand, China, and Australia: Drug Listing Changes and Opportunities

Value in Health

Occupational Health

English

From Phase Ii Studies to Hta Submissions: Optimal Use of Evidence for Informed Decisions

Value in Health

Occupational Health

English

Medicare Formulary Coverage and Restrictions for Opioid Potentiators From 2013 to 2017

Journal of General Internal Medicine

Internal Medicine

English

Correction: A Standardised Framework to Identify Optimal Animal Models for Efficacy Assessment in Drug Development

Multidisciplinary

English